BACKGROUND: Periconceptional folate is essential for proper neurodevelopment. OBJECTIVE: Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). DESIGN: Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to 2009 were included if their child had a diagnosis of ASD (n = 429), DD (n = 130), or typical development (TD; n = 278) confirmed at the University of California Davis Medical Investigation of Neurodevelopmental Disorders Institute by using standardized clinical assessments. Average daily folic acid was quantified for each mother on the basis of dose, brands, and intake frequency of vitamins, supplements, and breakfast cereals reported through structured telephone interviews. RESULTS: Mean (±SEM) folic acid intake was significantly greater for mothers of TD children than for mothers of children with ASD in the first month of pregnancy (P1; 779.0 ± 36.1 and 655.0 ± 28.7 μg, respectively; P < 0.01). A mean daily folic acid intake of ≥600 μg (compared with <600 μg) during P1 was associated with reduced ASD risk (adjusted OR: 0.62; 95% CI: 0.42, 0.92; P = 0.02), and risk estimates decreased with increased folic acid (P-trend = 0.001). The association between folic acid and reduced ASD risk was strongest for mothers and children with MTHFR 677 C>T variant genotypes. A trend toward an association between lower maternal folic acid intake during the 3 mo before pregnancy and DD was observed, but not after adjustment for confounders. CONCLUSIONS: Periconceptional folic acid may reduce ASD risk in those with inefficient folate metabolism. The replication of these findings and investigations of mechanisms involved are warranted.
BACKGROUND: Periconceptional folate is essential for proper neurodevelopment. OBJECTIVE: Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). DESIGN: Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to 2009 were included if their child had a diagnosis of ASD (n = 429), DD (n = 130), or typical development (TD; n = 278) confirmed at the University of California Davis Medical Investigation of Neurodevelopmental Disorders Institute by using standardized clinical assessments. Average daily folic acid was quantified for each mother on the basis of dose, brands, and intake frequency of vitamins, supplements, and breakfast cereals reported through structured telephone interviews. RESULTS: Mean (±SEM) folic acid intake was significantly greater for mothers of TD children than for mothers of children with ASD in the first month of pregnancy (P1; 779.0 ± 36.1 and 655.0 ± 28.7 μg, respectively; P < 0.01). A mean daily folic acid intake of ≥600 μg (compared with <600 μg) during P1 was associated with reduced ASD risk (adjusted OR: 0.62; 95% CI: 0.42, 0.92; P = 0.02), and risk estimates decreased with increased folic acid (P-trend = 0.001). The association between folic acid and reduced ASD risk was strongest for mothers and children with MTHFR 677 C>T variant genotypes. A trend toward an association between lower maternal folic acid intake during the 3 mo before pregnancy and DD was observed, but not after adjustment for confounders. CONCLUSIONS: Periconceptional folic acid may reduce ASD risk in those with inefficient folate metabolism. The replication of these findings and investigations of mechanisms involved are warranted.
Authors: Sheree L Boulet; Quanhe Yang; Cara Mai; Russell S Kirby; Julianne S Collins; James M Robbins; Robert Meyer; Mark A Canfield; Joe Mulinare Journal: Birth Defects Res A Clin Mol Teratol Date: 2008-07
Authors: Paolo Moretti; Sarika U Peters; Daniela Del Gaudio; Trilochan Sahoo; Keith Hyland; Teodoro Bottiglieri; Robert J Hopkin; Elizabeth Peach; Sang Hee Min; David Goldman; Benjamin Roa; Carlos A Bacino; Fernando Scaglia Journal: J Autism Dev Disord Date: 2007-11-20
Authors: Anne Lise Brantsaeter; Margaretha Haugen; Tor-Arne Hagve; Lage Aksnes; Salka E Rasmussen; Kåre Julshamn; Jan Alexander; Helle Margrete Meltzer Journal: Ann Nutr Metab Date: 2007-05-29 Impact factor: 3.374
Authors: Hyeong-Moo Shin; Deborah H Bennett; Antonia M Calafat; Daniel Tancredi; Irva Hertz-Picciotto Journal: Environ Res Date: 2020-04-14 Impact factor: 6.498
Authors: Adila Prasodjo; Christine M Pfeiffer; Zia Fazili; Yingying Xu; Stacey Liddy; Kimberly Yolton; David A Savitz; Bruce P Lanphear; Joseph M Braun Journal: Ann Epidemiol Date: 2014-04-24 Impact factor: 3.797
Authors: Tracy A Becerra; Ondine S von Ehrenstein; Julia E Heck; Jorn Olsen; Onyebuchi A Arah; Shafali S Jeste; Michael Rodriguez; Beate Ritz Journal: Pediatrics Date: 2014-07 Impact factor: 7.124
Authors: Todd P Whitehead; Catherine Metayer; Joseph L Wiemels; Amanda W Singer; Mark D Miller Journal: Curr Probl Pediatr Adolesc Health Care Date: 2016-10